Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES AJANTA PHARMA DIVIS LABORATORIES/
AJANTA PHARMA
 
P/E (TTM) x 30.0 23.8 125.9% View Chart
P/BV x 7.7 4.9 155.5% View Chart
Dividend Yield % 0.9 0.8 117.1%  

Financials

 DIVIS LABORATORIES   AJANTA PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
AJANTA PHARMA
Mar-22
DIVIS LABORATORIES/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs5,4251,614 336.1%   
Low Rs3,5621,089 327.2%   
Sales per share (Unadj.) Rs337.5391.1 86.3%  
Earnings per share (Unadj.) Rs111.583.4 133.7%  
Cash flow per share (Unadj.) Rs123.398.1 125.6%  
Dividends per share (Unadj.) Rs30.009.50 315.8%  
Avg Dividend yield %0.70.7 95.0%  
Book value per share (Unadj.) Rs441.8382.1 115.6%  
Shares outstanding (eoy) m265.4785.42 310.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.33.5 385.3%   
Avg P/E ratio x40.316.2 248.8%  
P/CF ratio (eoy) x36.513.8 264.7%  
Price / Book Value ratio x10.23.5 287.6%  
Dividend payout %26.911.4 236.3%   
Avg Mkt Cap Rs m1,192,890115,433 1,033.4%   
No. of employees `000NANA-   
Total wages/salary Rs m9,4626,458 146.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,59833,410 268.2%  
Other income Rs m1,1591,157 100.2%   
Total revenues Rs m90,75734,567 262.6%   
Gross profit Rs m38,8119,293 417.6%  
Depreciation Rs m3,1151,253 248.6%   
Interest Rs m20102 19.6%   
Profit before tax Rs m36,8359,095 405.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2311,968 367.4%   
Profit after tax Rs m29,6057,127 415.4%  
Gross profit margin %43.327.8 155.7%  
Effective tax rate %19.621.6 90.7%   
Net profit margin %33.021.3 154.9%  
BALANCE SHEET DATA
Current assets Rs m96,10424,548 391.5%   
Current liabilities Rs m24,5448,377 293.0%   
Net working cap to sales %79.948.4 165.0%  
Current ratio x3.92.9 133.6%  
Inventory Days Days942 20.8%  
Debtors Days Days98711 8,862.7%  
Net fixed assets Rs m50,08719,259 260.1%   
Share capital Rs m531172 309.2%   
"Free" reserves Rs m116,75132,469 359.6%   
Net worth Rs m117,28232,640 359.3%   
Long term debt Rs m016 0.0%   
Total assets Rs m146,19143,807 333.7%  
Interest coverage x1,842.890.2 2,043.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.8 80.4%   
Return on assets %20.316.5 122.8%  
Return on equity %25.221.8 115.6%  
Return on capital %31.428.2 111.6%  
Exports to sales %00-   
Imports to sales %19.70-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m17,676NA-   
Fx inflow Rs m78,44518,678 420.0%   
Fx outflow Rs m17,9533,662 490.2%   
Net fx Rs m60,49215,016 402.9%   
CASH FLOW
From Operations Rs m19,1185,620 340.2%  
From Investments Rs m-21,949-741 2,962.1%  
From Financial Activity Rs m-5,324-4,600 115.7%  
Net Cashflow Rs m-8,156279 -2,923.2%  

Share Holding

Indian Promoters % 51.9 70.5 73.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 21.4 169.4%  
FIIs % 15.4 8.2 187.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 29.5 162.8%  
Shareholders   379,257 62,048 611.2%  
Pledged promoter(s) holding % 0.0 17.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on Divis Laboratories vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs AJANTA PHARMA Share Price Performance

Period Divis Laboratories AJANTA PHARMA S&P BSE HEALTHCARE
1-Day -1.17% 1.22% -0.10%
1-Month -10.59% -6.90% -1.99%
1-Year -29.25% -11.30% -5.62%
3-Year CAGR 23.71% 23.81% 20.96%
5-Year CAGR 26.77% 7.06% 11.47%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of AJANTA PHARMA the stake stands at 70.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

AJANTA PHARMA paid Rs 9.5, and its dividend payout ratio stood at 11.4%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.